Skip to main content
Top
Published in: Inflammation 1/2014

01-02-2014

Effects of OX40–OX40L Interaction on the Nuclear Factor of Activated T Cells c1 in ApoE-Deficient Mice

Authors: Jin-chuan Yan, Liang-jie Xu, Cui-ping Wang, Zhong-qun Wang

Published in: Inflammation | Issue 1/2014

Login to get access

Abstract

We previously reported the emerging role of OX40–OX40L interaction in inflammation and atherosclerosis. However, the mechanism by which OX40–OX40L interaction contributes to pathogenesis is poorly understood. This study investigated the effects of OX40–OX40L interaction on the nuclear factor of activated T cells c1 (NFATc1) in ApoE−/− mice. Atherosclerotic plaque was induced via rapid perivascular carotid collar placement in ApoE−/− mice. The expression levels of OX40, OX40L, and NFATc1 in the lymphocytes were measured via real-time polymerase chain reaction and flow cytometry. The presence of NFATc1 in the atherosclerotic plaque was detected via immunohistochemistry, and the level of IL-4 was measured via enzyme-linked immunosorbent assay. The expression level of NFATc1 significantly increased in atherosclerotic lesion and in the leukocytes from the ApoE−/− mice. After stimulating OX40–OX40L interaction, the mRNA and protein expression levels of NFATc1 in the lymphocytes significantly increased. Meanwhile, anti-OX40LmAb significantly suppressed the expression of NFATc1 in the leukocytes and substantially elevated the level of IL-4. NFATc1 inhibitor markedly suppressed IL-4 production. This study suggests that OX40–OX40L interaction regulates the expression of NFATc1, which may play a critical role in atherosclerotic plaque formation, and may therefore have implications with pathophysiology of atherosclerosis.
Literature
1.
go back to reference Gotsman, I., A.H. Sharpe, and A.H. Lichtman. 2008. T-cell costimulation and coinhibition in atherosclerosis. Circ Res 103: 1220–1231.CrossRef Gotsman, I., A.H. Sharpe, and A.H. Lichtman. 2008. T-cell costimulation and coinhibition in atherosclerosis. Circ Res 103: 1220–1231.CrossRef
2.
go back to reference Van Wanrooij, E.J., G.H. van Puijvelde, P. de Vos, H. Yagita, T.J. van Berkel, and J. Kuiper. 2007. Interruption of the Tnfrsf4/Tnfsf4 (OX40/OX40L) pathway attenuates atherogenesis in low-density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol 27: 204–210.CrossRef Van Wanrooij, E.J., G.H. van Puijvelde, P. de Vos, H. Yagita, T.J. van Berkel, and J. Kuiper. 2007. Interruption of the Tnfrsf4/Tnfsf4 (OX40/OX40L) pathway attenuates atherogenesis in low-density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol 27: 204–210.CrossRef
3.
go back to reference Hogan, P.G., L. Chen, J. Nardone, and A. Rao. 2003. Transcriptional regulation by calcium calcineurin, and NFAT. Genes Dev 17: 2205–2232.CrossRef Hogan, P.G., L. Chen, J. Nardone, and A. Rao. 2003. Transcriptional regulation by calcium calcineurin, and NFAT. Genes Dev 17: 2205–2232.CrossRef
4.
go back to reference Macian, F. 2005. NFAT proteins: Key regulators of T-cell development and function. Nat Rev Immunol 5: 472–484.CrossRef Macian, F. 2005. NFAT proteins: Key regulators of T-cell development and function. Nat Rev Immunol 5: 472–484.CrossRef
5.
go back to reference Macian, F., C. Garcia-Rodriguez, and A. Rao. 2000. Gene expression elicited by NFAT in the presence or absence of cooperative recruitment of Fos and Jun. EMBO J 19: 4783–4795.CrossRef Macian, F., C. Garcia-Rodriguez, and A. Rao. 2000. Gene expression elicited by NFAT in the presence or absence of cooperative recruitment of Fos and Jun. EMBO J 19: 4783–4795.CrossRef
6.
go back to reference de la Pompa, J.L., L.A. Timmerman, H. Takimoto, H. Yoshida, A.J. Elia, E. Samper, J. Potter, A. Wakeham, L. Marengere, B.L. Langille, G.R. Crabtree, and T.W. Mak. 1998. Role of the NF-ATc transcription factor in morphogenesis of cardiac valves and septum. Nature 392: 182–186.CrossRef de la Pompa, J.L., L.A. Timmerman, H. Takimoto, H. Yoshida, A.J. Elia, E. Samper, J. Potter, A. Wakeham, L. Marengere, B.L. Langille, G.R. Crabtree, and T.W. Mak. 1998. Role of the NF-ATc transcription factor in morphogenesis of cardiac valves and septum. Nature 392: 182–186.CrossRef
7.
go back to reference Ranger, A.M., M.J. Grusby, M.R. Hodge, E.M. Gravallese, F.C. de la Brousse, T. Hoey, C. Mickanin, H.S. Baldwin, and L.H. Glimcher. 1998. The transcription factor NF-ATc is essential for cardiac valve formation. Nature 392: 186–190.CrossRef Ranger, A.M., M.J. Grusby, M.R. Hodge, E.M. Gravallese, F.C. de la Brousse, T. Hoey, C. Mickanin, H.S. Baldwin, and L.H. Glimcher. 1998. The transcription factor NF-ATc is essential for cardiac valve formation. Nature 392: 186–190.CrossRef
8.
go back to reference Sieber, M., and R. Baumgrass. 2009. Novel inhibitors of the calcineurin/NFATc hub—Alternatives to CsA and FK506. Cell Commun Signal 7: 25.CrossRef Sieber, M., and R. Baumgrass. 2009. Novel inhibitors of the calcineurin/NFATc hub—Alternatives to CsA and FK506. Cell Commun Signal 7: 25.CrossRef
9.
go back to reference Karpurapu, M., D. Wang, N.K. Singh, Q. Li, and G.N. Rao. 2008. NFATc1 targets cyclin A in the regulation of vascular smooth muscle cell multiplication during restenosis. J Biol Chem 283: 26577–26590.CrossRef Karpurapu, M., D. Wang, N.K. Singh, Q. Li, and G.N. Rao. 2008. NFATc1 targets cyclin A in the regulation of vascular smooth muscle cell multiplication during restenosis. J Biol Chem 283: 26577–26590.CrossRef
10.
go back to reference Croft, M. 2003. Co-stimulatory members of the TNFR family: Keys to effective T-cell immunity? Nat Rev Immuno 3: 609–620.CrossRef Croft, M. 2003. Co-stimulatory members of the TNFR family: Keys to effective T-cell immunity? Nat Rev Immuno 3: 609–620.CrossRef
11.
go back to reference Watts, T.H. 2005. TNF/TNFR family members in costimulation of T cell responses. Annu Rev Immunol 23: 23–68.CrossRef Watts, T.H. 2005. TNF/TNFR family members in costimulation of T cell responses. Annu Rev Immunol 23: 23–68.CrossRef
12.
go back to reference Sugamura, K., N. Ishii, and A.D. Weinberg. 2004. Therapeutic targeting of the effector T-cell co-stimulatory molecule OX40. Nat Rev Immunol 4: 420–431.CrossRef Sugamura, K., N. Ishii, and A.D. Weinberg. 2004. Therapeutic targeting of the effector T-cell co-stimulatory molecule OX40. Nat Rev Immunol 4: 420–431.CrossRef
13.
go back to reference Monticelli, S., and A. Rao. 2002. NFAT1 and NFAT2 are positive regulators of IL-4 gene transcription. Eur J Immunol 32: 2971–2978.CrossRef Monticelli, S., and A. Rao. 2002. NFAT1 and NFAT2 are positive regulators of IL-4 gene transcription. Eur J Immunol 32: 2971–2978.CrossRef
14.
go back to reference Liu, D.M., J.C. Yan, C.P. Wang, G.H. Chen, S. Ding, P.J. Liu, and R.Z. Du. 2008. The clinical implications of increased OX40 ligand expression in patients with acute coronary syndrome. Clin Chim Acta 397: 22–26.CrossRef Liu, D.M., J.C. Yan, C.P. Wang, G.H. Chen, S. Ding, P.J. Liu, and R.Z. Du. 2008. The clinical implications of increased OX40 ligand expression in patients with acute coronary syndrome. Clin Chim Acta 397: 22–26.CrossRef
15.
go back to reference von der Thusen, J.H., T.J. van Berkel, and E.A. Biessen. 2001. Induction of rapid atherogenesis by perivascular carotid collar placement in apolipoprotein E-deficient and low-density lipoprotein receptor-deficient mice. Circulation 103: 1164–1170.CrossRef von der Thusen, J.H., T.J. van Berkel, and E.A. Biessen. 2001. Induction of rapid atherogenesis by perivascular carotid collar placement in apolipoprotein E-deficient and low-density lipoprotein receptor-deficient mice. Circulation 103: 1164–1170.CrossRef
16.
go back to reference Takeda, I., S. Ine, N. Killeen, L.C. Ndhlovu, K. Murata, S. Satomi, K. Sugamura, and N. Ishii. 2004. Distinct roles for the OX40–OX40 ligand interaction in regulatory and nonregulatory T cells. J Immunol 172: 3580–3589.CrossRef Takeda, I., S. Ine, N. Killeen, L.C. Ndhlovu, K. Murata, S. Satomi, K. Sugamura, and N. Ishii. 2004. Distinct roles for the OX40–OX40 ligand interaction in regulatory and nonregulatory T cells. J Immunol 172: 3580–3589.CrossRef
17.
go back to reference Peng, D.Q., S. Huang, S.G. Yuan, and S.P. Zhao. 2010. Increased soluble OX40L is associated with carotid intima-media thickness. Clin Lab 56: 449–457.PubMed Peng, D.Q., S. Huang, S.G. Yuan, and S.P. Zhao. 2010. Increased soluble OX40L is associated with carotid intima-media thickness. Clin Lab 56: 449–457.PubMed
18.
go back to reference Nakano, M., Y. Fukumoto, K. Satoh, Y. Ito, Y. Kagaya, N. Ishii, K. Sugamura, and H. Shimokawa. 2010. OX40 ligand plays an important role in the development of atherosclerosis through vasa vasorum neovascularization. Cardiovasc Res 88: 539–546.CrossRef Nakano, M., Y. Fukumoto, K. Satoh, Y. Ito, Y. Kagaya, N. Ishii, K. Sugamura, and H. Shimokawa. 2010. OX40 ligand plays an important role in the development of atherosclerosis through vasa vasorum neovascularization. Cardiovasc Res 88: 539–546.CrossRef
19.
go back to reference Yan, J., C. Wang, R. Du, P. Liu, and G. Chen. 2009. OX40–OX40L ligand interaction may activate phospholipase C signal transduction pathway in human umbilical vein endothelial cells. Chem Biol Interact 180: 460–464.CrossRef Yan, J., C. Wang, R. Du, P. Liu, and G. Chen. 2009. OX40–OX40L ligand interaction may activate phospholipase C signal transduction pathway in human umbilical vein endothelial cells. Chem Biol Interact 180: 460–464.CrossRef
20.
go back to reference Kim, M.S., and Y.M. Usachev. 2009. Mitochondrial Ca2+ cycling facilitates activation of the transcription factor NFAT in sensory neurons. J Neurosci 29: 12101–12114.CrossRef Kim, M.S., and Y.M. Usachev. 2009. Mitochondrial Ca2+ cycling facilitates activation of the transcription factor NFAT in sensory neurons. J Neurosci 29: 12101–12114.CrossRef
Metadata
Title
Effects of OX40–OX40L Interaction on the Nuclear Factor of Activated T Cells c1 in ApoE-Deficient Mice
Authors
Jin-chuan Yan
Liang-jie Xu
Cui-ping Wang
Zhong-qun Wang
Publication date
01-02-2014
Publisher
Springer US
Published in
Inflammation / Issue 1/2014
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-013-9731-y

Other articles of this Issue 1/2014

Inflammation 1/2014 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.